The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The proportion and characterization of patients with metastatic renal cell carcinoma who are never treated or have delayed treatment with targeted therapy: Results from a large prospective cohort.
 
Paramjot Bains
No Relationships to Disclose
 
Daniel Yick Chin Heng
Consulting or Advisory Role - AVEO; Bayer; Novartis; Pfizer
 
Jennifer J. Knox
No Relationships to Disclose
 
Georg A. Bjarnason
No Relationships to Disclose
 
Christian K. Kollmannsberger
No Relationships to Disclose
 
Sebastien J. Hotte
Consulting or Advisory Role - Astellas Pharma; Janssen
 
Anil Kapoor
Honoraria - Amgen; GlaxoSmithKline; Novartis; Pfizer
Speakers' Bureau - Amgen; GlaxoSmithKline; Novartis; Pfizer
Research Funding - Novartis
 
Marie Vanhuyse
Consulting or Advisory Role - Astellas Pharma; Bayer Schering Pharma; Pfizer; Sanofi
Research Funding - sanofi (Inst)
 
M. Neil Neil Reaume
Consulting or Advisory Role - GlaxoSmithKline; Janssen; Novartis; Pfizer; Sanofi
 
Piotr Czaykowski
No Relationships to Disclose
 
Denis Soulieres
No Relationships to Disclose
 
Naveen S. Basappa
Honoraria - Astellas Pharma; Janssen; Novartis; Pfizer; Sanofi
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; Janssen; Novartis; Pfizer; Trelstar
Research Funding - Pfizer (Inst)
 
Olli Saarela
No Relationships to Disclose
 
Lori Wood
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Novartis
Other Relationship - Janssen Oncology; Pfizer